Key regions: France, Australia, India, South Korea, Germany
The Other OTC Pharmaceuticals (Pharmacies) market in France has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in France have played a crucial role in driving the growth of the Other OTC Pharmaceuticals market. French consumers are increasingly seeking convenience and accessibility when it comes to purchasing healthcare products. They prefer to have easy access to a wide range of over-the-counter medications and healthcare products, which can be conveniently obtained from pharmacies. The French population also values the expertise and advice provided by pharmacists, who are seen as trusted healthcare professionals. This preference for pharmacies as a one-stop-shop for healthcare products has fueled the growth of the Other OTC Pharmaceuticals market. Trends in the market have further supported the development of the Other OTC Pharmaceuticals market in France. One notable trend is the increasing demand for natural and organic healthcare products. French consumers are becoming more conscious about the ingredients and composition of the products they use, and are opting for natural alternatives. This trend has led to the emergence of a wide range of natural and organic OTC pharmaceuticals in the market, catering to the growing demand. Additionally, there has been a shift towards online purchasing of healthcare products, with more consumers opting for the convenience of online pharmacies. This trend has further expanded the reach of the Other OTC Pharmaceuticals market in France. Local special circumstances have also contributed to the growth of the Other OTC Pharmaceuticals market in France. The French healthcare system places a strong emphasis on self-medication and encourages individuals to take responsibility for their own health. This cultural norm has created a favorable environment for the OTC Pharmaceuticals market to thrive. Furthermore, the presence of a large number of pharmacies in France, both in urban and rural areas, ensures easy accessibility to OTC pharmaceuticals for all segments of the population. This accessibility has played a crucial role in driving the growth of the market. Underlying macroeconomic factors have also played a significant role in the development of the Other OTC Pharmaceuticals market in France. The country's stable economy and high disposable income levels have contributed to increased consumer spending on healthcare products. Additionally, the aging population in France has led to a higher demand for OTC pharmaceuticals, as older individuals often require medications for chronic conditions. These macroeconomic factors have created a favorable market environment for the growth of the Other OTC Pharmaceuticals market in France. In conclusion, the Other OTC Pharmaceuticals market in France has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The convenience and accessibility offered by pharmacies, the demand for natural and organic healthcare products, the cultural norm of self-medication, and the country's stable economy and aging population have all contributed to the development of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
